The Manufacturers Life Insurance Company lifted its position in STAAR Surgical Company (NASDAQ:STAA) by 0.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,653 shares of the medical instruments supplier’s stock after purchasing an additional 34 shares during the quarter. The Manufacturers Life Insurance Company owned 0.08% of STAAR Surgical worth $341,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp raised its stake in STAAR Surgical by 7.8% during the second quarter. State Street Corp now owns 684,125 shares of the medical instruments supplier’s stock worth $7,390,000 after acquiring an additional 49,362 shares in the last quarter. Palo Alto Investors LLC raised its stake in STAAR Surgical by 1.6% during the second quarter. Palo Alto Investors LLC now owns 3,529,070 shares of the medical instruments supplier’s stock worth $38,114,000 after acquiring an additional 55,900 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in STAAR Surgical by 68.1% during the second quarter. Goldman Sachs Group Inc. now owns 19,073 shares of the medical instruments supplier’s stock worth $206,000 after acquiring an additional 7,729 shares in the last quarter. Voya Investment Management LLC raised its stake in STAAR Surgical by 15.6% during the second quarter. Voya Investment Management LLC now owns 21,777 shares of the medical instruments supplier’s stock worth $235,000 after acquiring an additional 2,942 shares in the last quarter. Finally, Virtu KCG Holdings LLC acquired a new position in STAAR Surgical during the second quarter worth $118,000. Institutional investors and hedge funds own 77.73% of the company’s stock.

In other news, VP Keith Holliday sold 6,000 shares of the firm’s stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $16.65, for a total value of $99,900.00. Following the completion of the sale, the vice president now directly owns 45,969 shares in the company, valued at $765,383.85. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 5.60% of the company’s stock.

STAA has been the subject of several recent analyst reports. Canaccord Genuity reiterated a “buy” rating and set a $15.00 price objective on shares of STAAR Surgical in a research note on Sunday, October 8th. Zacks Investment Research upgraded STAAR Surgical from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a research note on Saturday, September 23rd. Benchmark reiterated a “buy” rating and set a $21.00 price objective on shares of STAAR Surgical in a research note on Monday, November 20th. TheStreet upgraded STAAR Surgical from a “d+” rating to a “c” rating in a research note on Tuesday, August 15th. Finally, BidaskClub upgraded STAAR Surgical from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $17.67.

Shares of STAAR Surgical Company (NASDAQ:STAA) opened at $16.95 on Friday. STAAR Surgical Company has a 12 month low of $8.95 and a 12 month high of $17.60. The company has a current ratio of 2.24, a quick ratio of 1.72 and a debt-to-equity ratio of 0.02.

ILLEGAL ACTIVITY NOTICE: “The Manufacturers Life Insurance Company Purchases 34 Shares of STAAR Surgical Company (STAA)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2017/12/02/the-manufacturers-life-insurance-company-purchases-34-shares-of-staar-surgical-company-staa.html.

About STAAR Surgical

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

Receive News & Stock Ratings for STAAR Surgical Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical Company and related stocks with our FREE daily email newsletter.